Possis to Release Second Quarter Results on February 20

  
    
  
  
    
      Possis Medical, Inc. (NASDAQ: POSS), a developer, manufacturer and 
      distributor of pioneering medical devices used in endovascular 
      procedures, announced today that it will report complete results for its 
      second quarter ended January 31, 2008, at 7:00 a.m. (CT) on Feb. 20, 
      2008. Based on preliminary results, Possis indicated that it currently 
      expects net sales of approximately $20.6 million for the second quarter, 
      a 30 percent increase from fiscal 2007 second-quarter sales of $15.8 
      million. In its outlook issued on Nov. 21, 2007, the Company had 
      estimated second-quarter net sales of $18.7 million to $19.2 million. 
      Possis anticipates second quarter net income to fall within its 
      previously issued guidance range of $0.03 to $0.05 per diluted share, 
      compared to a net loss of $0.04 per diluted share in the second quarter 
      of fiscal 2007.
    
    
      The full release at 7:00 a.m. (CT) on February 20 will include summary 
      financial information for Possis’ second 
      quarter. Possis will hold a shareholder conference call on Wednesday, 
      Feb. 20, 2008, beginning at 9:30 a.m. (CT). Management will review 
      second-quarter financial and operating results, and discuss its future 
      outlook. To join the conference call, dial 1-800-762-8779 (international 
      1-480-248-5081). A replay of the conference call will be available one 
      hour after the call ends through 11:59 P.M. (CT) on Feb. 22, 2008. To 
      access the replay, dial 1-800-406-7325 (international 1-303-590-3030) 
      and use the access code 3804797.
    
    
      For individual investors, a Webcast of the conference call will be 
      available at www.possis.com under 
      the "Investors" tab, or at www.fulldisclosure.com. 
      Institutional investors can access the Webcast through a 
      password-protected site at www.streetevents.com. 
      An archived Webcast of Possis’ conference call 
      will be available for 30 days.
    
    
      About Possis Medical, Inc.
    
    
      Possis Medical, Inc., develops, manufactures and markets pioneering 
      medical devices for the large and growing cardiovascular and vascular 
      treatment markets. The company's AngioJet® 
      System is the world's leading mechanical thrombectomy system with FDA 
      approval to remove large and small thrombus from coronary arteries, 
      coronary bypass grafts, peripheral arteries and veins, A-V grafts and 
      native fistulas.
    
    
      Certain statements in this press release constitute "forward-looking 
      statements" within the meaning of Federal Securities Laws. These 
      statements are based on our current expectations and assumptions, and 
      entail various risks and uncertainties that could cause actual results 
      to differ materially from those expressed in such forward-looking 
      statements. A discussion of these and other factors that could impact 
      the Company's future results are set forth in the cautionary statements 
      included in the Company's Form 10-K for the year ended July 31, 2007, 
      filed with the Securities and Exchange Commission.